MNPR - Monopar Therapeutics
39.42
-2.950 -7.484%
Share volume: 48,523
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$42.37
-2.95
-0.07%
Summary score
26%
Profitability
18%
Dept financing
2%
Liquidity
50%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2015 - 30-Jun-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-24.08%
Return on assets
-11.81%
Return on sales
0%
Return on invested capital
-173.62%
Total debt ratio
4.58%
Debt ratio change over timeo
0%
Current Ratio
23.15%
Quick Ratio
0%
Cash Position Ratio
22.7%
Short-term ratios 30-Jun-2018 - 30-Jun-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.71%
Return on assets
-15.23%
Return on sales
0%
Return on invested capital
504.8%
Total debt ratio
6.73%
Debt ratio change over timeo
0%
Current Ratio
16.27%
Quick Ratio
0%
Cash Position Ratio
15.69%
Last quarter ratios 30-Jun-2019
The data are presented for the financials results of the last quarter.
Return on equity
-17.67%
Return on assets
-16.66%
Return on sales
0%
Return on invested capital
932.18%
Total debt ratio
8.37%
Debt ratio change over time
0%
Current Ratio
11.16%
Quick Ratio
0%
Cash Position Ratio
10.95%
Performance ratios (change over 4 years) 30-Jun-2015 - 30-Jun-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MNPR | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -24.08% | 8.59% | 4.18% | 20.53% |
| Return on assets | -11.81% | 3.2% | 3.39% | 11.94% |
| Return on sales | 0% | 22.93% | 26.31% | 42.56% |
| Return on invested capital | -173.62% | 3.7% | 4.17% | -285.22% |
| Profitability | 0% | 53% | 53% | 75% |
| Total debt ratio | 4.58% | 72.07% | 56.42% | 53.43% |
| Debt ratio change over time | 0% | 0% | 8.97% | 0% |
| Dept financing | 2% | 25% | 45% | 19% |
| Current Ratio | 16.27% | 1.47% | 1.49% | 1.05% |
| Quick Ratio | 0% | 1.16% | 1.19% | 0.74% |
| Cash Position Ratio | 15.69% | 0.47% | 0.59% | 0.26% |
| Liquididy | 50% | 21% | 28% | 16% |
| Short-term ratios | MNPR | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -15.71% | 22.65% | 6.69% | 18.89% |
| Return on assets | -15.23% | 3.51% | 3.37% | 11.22% |
| Return on sales | 0% | 24.97% | 25.42% | 42.3% |
| Return on invested capital | 504.8% | 8.12% | 5.12% | -30.83% |
| Profitability | 25% | 48% | 30% | 71% |
| Total debt ratio | 6.73% | 83.65% | 60.24% | 54.65% |
| Debt ratio change over time | 0% | 0% | 12.17% | 0% |
| Dept financing | 2% | 25% | 43% | 16% |
| Current Ratio | 16.27% | 1.47% | 1.49% | 1.05% |
| Quick Ratio | 0% | 1.16% | 1.19% | 0.74% |
| Cash Position Ratio | 15.69% | 0.47% | 0.59% | 0.26% |
| Liquididy | 50% | 27% | 28% | 18% |
